Blue Clay Capital Management’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-74,205	Closed	-$122K	–	93
2015 Q4	$122K	Sell	74,205 -262	-0.4%	-$431	0.1%	76
2015 Q3	$174K	Hold	74,467	–	–	0.14%	74
2015 Q2	$203K	Buy	+74,467	New	+$203K	0.11%	64